Skip to main menu Skip to main content Skip to footer
neurotech logo
  • Accessibility Menu
  • About Us
    • Our Team
    • Careers
    • Contact Us
  • Our Newly Approved Product
  • Science & Technology
    • Publications
  • Clinical
  • Patients
  • News

Neurotech Pharmaceuticals Announces Positive Phase 3 Topline Results for NT-501 Implant in MacTel

Home » Neurotech Pharmaceuticals Announces Positive Phase 3 Topline Results for NT-501 Implant in MacTel

Press Release – Phase 3 Trials

Other Posts

<< Previous
Next >>

Media Contact

Laurie Ferguson
l.ferguson@neurotechusa.com

neurotech logo
About Us Science & Technology Clinical Patients News Careers Publications Contact Us Supplier Code of Conduct Policy Accessibility Statement Privacy Policy Terms and Conditions of Use Policy
Stay Connected with our
Linked
,
Twitter
,
and
Instagram
,
accounts
Main Phone Number
Phone Icon 401-333-3880
Headquarters
Map Pin Icon
900 Highland Corporate Drive, Suite 101
Cumberland, RI 02864
Commercial Office
Map Pin Icon
75 Second Ave, Suite 700
Needham, MA 02494
© Neurotech Pharmaceuticals, Inc. 2025
Designed by Glacial Multimedia.
⇧